Pharmacy in FR. Official registry identity, source coverage and the current valuation evidence status on one public company profile.
SELARL GRANDE PHARMACIE DES SALINES has public figures, but the legal status or filing freshness makes an automated going-concern multiple misleading. Verify current continuity and owner context before showing a range.
Create a free account to add verified turnover, normalised EBITDA, debt and one-offs for SELARL GRANDE PHARMACIE DES SALINES in a private workspace.
We keep this public page conservative, so weak filings never become a false price.The page can still show filed facts, but the automatic public range is blocked when those facts would make the multiple misleading.
SELARL GRANDE PHARMACIE DES SALINES, a pharmacy, is registered at an address in France. The company was founded in 2002, incorporated as a 5785.
SELARL GRANDE PHARMACIE DES SALINES is listed in French National Business Register (RNE/INPI) under registry number 443459813. The public employee band is 11, a useful triage field for banks, credit analysts, and M&A acquirers. This profile consolidates official annual accounts into one indexable company dossier.
Companies in this NACE 47.73 band file annual accounts with INPI.
The most recent annual filing covers 2022 (period end 2022-06-30).
The data on this page is a public, point-in-time view of SELARL GRANDE PHARMACIE DES SALINES's regulator-filed footprint, built to support sellability context and acquisition research without overstating the public valuation evidence.
SELARL GRANDE PHARMACIE DES SALINES's public data is not clean enough for an automated valuation curve yet. Owner or advisor data can add the missing turnover, normalised EBITDA and adjustments.
Express interest and ask Upswitch to discreetly sound out the owner. We review every request before making contact.
This is an estimate, not an asking price. It is based on dated public sources and is not an owner forecast, offer, investment advice, or confirmation that the company is for sale.
Request verified control to add current figures, improve the profile and manage what happens next. We verify ownership before granting access.
Public regulator-filed figures across 8 years.
Fiscal year | Revenue | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202530 Jun 2025 | - | - | €2,908,144 | €900,667 | - |
| 202430 Apr 2024 | - | - | €2,579,300 | €465,285 | - |
| 202330 Apr 2023 | - | - | €3,416,480 | €2,594,200 | - |
| 202230 Jun 2022 | €4,617,320 | - | €3,529,892 | €2,518,784 | - |
| 202130 Jun 2021 | €3,960,505 | - | €3,535,668 | €2,371,097 | - |
| 202030 Jun 2020 | €3,754,166 | - | €3,482,228 | €2,029,887 | - |
| 201930 Jun 2019 | €3,505,988 | - | €3,438,535 | €1,936,650 | - |
| 201830 Jun 2018 | €3,434,085 | - | €3,459,796 | €1,851,269 | - |
SELARL GRANDE PHARMACIE DES SALINES was founded in 2002 and is registered with French National Business Register (RNE/INPI), incorporated as a 5785.
SELARL GRANDE PHARMACIE DES SALINES is registered under NACE 47.73: NACE 47.73. That places the business within the French cluster for this activity.
The most recently filed annual accounts cover fiscal year 2022 (period end 2022-06-30), publicly available via French National Business Register (RNE/INPI).
This page shows official or licensed public company facts and valuation-readiness context for SELARL GRANDE PHARMACIE DES SALINES; it does not show an automated public valuation range. The available facts may be incomplete or inaccurate and must not be relied upon for any transaction; a precise valuation needs owner- or advisor-supplied data.
Company identity and public facts are reused from the official or licensed source named on this page, with its filing or update date. Upswitch estimates remain distinct from source facts and do not imply endorsement by the registry. Natural-person enterprises are excluded from public valuation pages, and public registry personal data is not used for direct marketing.
Connected to this company and want something corrected? Request a correction or removal · Privacy policy · Terms & conditions · Data sources & evidence
